for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Camlin Fine Sciences Ltd

CAMF.NS

Latest Trade

71.75INR

Change

4.10(+6.06%)

Volume

1,028,804

Today's Range

69.00

 - 

73.00

52 Week Range

38.70

 - 

73.00

As of on the National Stock Exchange of India ∙ Minimum 15 minute delay

Pricing

Previous Close
67.65
Open
69.80
Volume
1,028,804
3M AVG Volume
3.33
Today's High
73.00
Today's Low
69.00
52 Week High
73.00
52 Week Low
38.70
Shares Out (MIL)
121.25
Market Cap (MIL)
7,705.69
Forward P/E
15.50
Dividend (Yield %)
--

Latest Developments

More

India's Camlin Fine Sciences Sept Quarter Consol Profit Rises

India's Camlin Fine Sciences Reports Profit In June Quarter

Camlin Fine Sciences Says CFCL Mauritius Reverse Merged With CFS Europe S.P.A, Italy

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Camlin Fine Sciences Ltd

Camlin Fine Sciences Limited is engaged in fine chemicals business. The Company is a provider of antioxidants and shelf life extensions, aroma ingredients, performance chemical products and related solutions for food, animal nutrition, pet food, pharmaceutical and petrochemical industries across the world. Its products include BHA and TBHQ. The Company's offerings in shelf life solutions include XTENDRA, NASURE, REDOX, ENERSUPRA, RENDEROX, POLIACID and BIACID. It produces Catechol, the ingredient used to make Vanillin and Ethyl-Vanillin, that is used in a range of applications, such as bakery products, confectioneries, chocolates, supplements, milk, sweets, custard powder, masala incense stick, scented incense stick, pharma syrups, animal nutrition, chew tablets and laboratory chemicals. Its performance chemicals business is involved in providing specialty chemicals, including Guaiacol, Veratrole, TBC, MEHQ, ODEB, CME, 4-MAP, Hydroquinone and Catechol.

Industry

Chemical Manufacturing

Contact Info

Plot No F/11 & F/12,Wicel Compound

Opp Seepz Main Gate, Midc Central Road

+91.22.67001000

https://www.camlinfs.com/

Executive Leadership

Dilip D. Dandekar

Non-Executive Chairman of the Board

Dattatraya R. Puranik

Chief Financial Officer, Executive Director

Ashish S. Dandekar

Managing Director, Executive Director

Arjun Sudhakar Dukane

Executive Director

Anagha S. Dandekar

Additional Non-Executive Director

Key Stats

1.50 mean rating - 2 analysts
Sell
Hold
Buy
Revenue (MM, INR)

2017

5.5K

2018

7.2K

2019

8.9K

2020(E)

11.1K
EPS (INR)

2017

-1.400

2018

-0.380

2019

0.050

2020(E)

4.100
Price To Earnings (TTM)
27.73
Price To Sales (TTM)
0.78
Price To Book (MRQ)
2.02
Price To Cash Flow (TTM)
13.09
Total Debt To Equity (MRQ)
137.75
LT Debt To Equity (MRQ)
52.16
Return on Investment (TTM)
5.10
Return on Equity (TTM)
2.65

Latest News

Latest News

BRIEF-Camlin Fine Sciences Enters Into JV Agreement With Singapore's Pahang Pharma

* ENTERED INTO AN JOINT VENTURE AGREEMENT WITH PAHANG PHARMA (S) PTE LTD Source text: http://bit.ly/2Ja1e7P Further company coverage:

BRIEF-India's Camlin Fine Sciences Dec Qtr Consol Loss Widens

* DEC QUARTER CONSOL NET LOSS 103.2 MILLION RUPEES VERSUS LOSS 47.2 MILLION RUPEES YEAR AGO

BRIEF-Camlin Fine Sciences Approves Issue Price Of 92.69 Rupees Per Warrant For Preferential Allotment

* SAYS APPROVED ISSUE PRICE OF 92.69 RUPEES PER WARRANT FOR THE PREFERENTIAL ALLOTMENT OF WARRANTS Source text: http://bit.ly/2pQIuEF Further company coverage:

BRIEF-Camlin Fine Sciences Gets Shareholders' Nod For Preferential Allotment Of Warrants

* GETS SHAREHOLDERS' NOD FOR PREFERENTIAL ALLOTMENT OF WARRANTS Source text: http://bit.ly/2pBhQQ0 Further company coverage:

BRIEF-India's Camlin Fine Sciences says SBI Mutual Fund raises stake in co by 5.9 pct

* Says SBI Mutual Fund raises stake in co by 5.9 percent to 7.27 percent

BRIEF-Camlin Fine Sciences approve issue of shares worth 1.50 bln rupees via QIP

* Says approved issue of 17.2 million shares worth 1.50 billion rupees via QIP Source text : http://bit.ly/2jimV9w Further company coverage:

BRIEF-India's Camlin Fine Sciences sets QIP issue price at 87 rupees per shr

* Says approved issue price of QIP at 87 rupees per equity share

BRIEF-Camlin Fine Sciences ‍enters preferred supply agreement with Lockheed Martin Advanced Energy Storage​

* Says co entered into preferred supply agreement with Lockheed Martin Advanced Energy Storage

BRIEF-Camlin Fine Sciences Sept-qtr consol loss widens

* Sept quarter consol loss 41.5 million rupees versus loss 5.9 million rupees year ago

BRIEF-India's Camlin Fine Sciences posts June-qtr loss

* June quarter loss after tax 35.5 million rupees versus profit 63.5 million rupees year ago

BRIEF-Camlin Fine Sciences buys stake in entity in China

* Says company has along with its subsidiary cfs europe spa, italy has acquired 51% stake in an entity in china.

BRIEF-Camlin Fine Sciences says co, Italy unit buys 51 pct stake in Ningbo Wanglong Flavors and Fragrances

* Camlin Fine Sciences - co along with CFS Europe SPA, Italy has acquired 51 percent stake in an entity in China

BRIEF-Camlin Fine Sciences to consider raising funds

* Says to consider raising funds not exceeding inr 2.50 billion by way of QIP/GDR/ADR/FCCB/other securities Source text for Eikon: Further company coverage:

BRIEF-Camlin Fine Sciences directed to shut manufacturing activities of Tarapur unit

* Directed by Maharashtra Pollution Control brd to close manufacturing activities of Tarapur unit for violation of consent conditions

BRIEF-Camlin Fine Sciences posts Dec qtr consol loss

* Dec quarter consol net loss 49.3 million rupees versus profit 26.1 million rupees year ago

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up